Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Genetic and environmental risk factors for idiopathic inflammatory myopathies
2002
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Molecular biology of distal muscular dystrophies—Sarcomeric proteins on top
2006
Inclusion body myositis and myopathies
1995 Standout
Rheumatoid arthritis
2018 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Molecular Mechanism of Basic Calcium Phosphate Crystal-induced Activation of Human Fibroblasts
1998
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results
1996
Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects
2002 Standout
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Distal myopathies 25th ENMC international workshop 18–20 November 1994, Naarden, The Netherlands
1995
Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
2003
Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen‐month, randomized, double‐blind, placebo‐controlled, crossover trial
2005
Prevalence of Muscular Dystrophies: A Systematic Literature Review
2014 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Cyclosporin
1993
Current Pharmacological Treatment of Osteoarthritis
1996
Update on the genetics of the idiopathic inflammatory myopathies
2000
Inclusion body myositis
2007
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study
2001
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review
2003
Polymyositis and dermatomyositis
2003 Standout
Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria
2002
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis
1999
Management of Crohn's Disease in Adults
2009 Standout
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
2007
Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana
2018 StandoutNobel
Inflammatory Muscle Diseases
2015 Standout
HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies
1998
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction
2014
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Genetic Biomarkers in Hypertrophic Cardiomyopathy
2013
Works of B.A. Laing being referenced
A randomised double‐blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis
1991
Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxicam.
1992
Autosomal dominant distal myopathy: linkage to chromosome 14
1993
Autosomal dominant distal myopathy: linkage to chromosome 14.
1995
Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1 beta.
1991
HLA associations with inclusion body myositis
1994
Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.
1991
Comparison of two yttrium-90 regimens in inflammatory and osteoarthropathies.
1992